BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28750401)

  • 1. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
    Stanta G; Bonin S
    Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
    Biswas A; De S
    Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
    Li L; Chen C; Wang X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview on Clinical Relevance of Intra-Tumor Heterogeneity.
    Stanta G; Bonin S
    Front Med (Lausanne); 2018; 5():85. PubMed ID: 29682505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
    Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
    Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
    Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
    OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral Heterogeneity of the Epigenome.
    Mazor T; Pankov A; Song JS; Costello JF
    Cancer Cell; 2016 Apr; 29(4):440-451. PubMed ID: 27070699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumor heterogeneity: evolution through space and time.
    Swanton C
    Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
    Kim M; Lee S; Lim S; Kim S
    PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour heterogeneity: principles and practical consequences.
    Stanta G; Jahn SW; Bonin S; Hoefler G
    Virchows Arch; 2016 Oct; 469(4):371-84. PubMed ID: 27412632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
    Brychtová V; Valík V; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.
    Andor N; Graham TA; Jansen M; Xia LC; Aktipis CA; Petritsch C; Ji HP; Maley CC
    Nat Med; 2016 Jan; 22(1):105-13. PubMed ID: 26618723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumor heterogeneity: A new perspective on colorectal cancer research.
    Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
    Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and non-genetic clonal diversity in cancer evolution.
    Black JRM; McGranahan N
    Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Heterogeneity: Will It Change What Pathologists Do.
    Bosman FT
    Pathobiology; 2018; 85(1-2):18-22. PubMed ID: 28482346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
    Song D; Wang X
    J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
    McGranahan N; Swanton C
    Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.